Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients

被引:9
作者
Ruiz-Idiago, Jesus [1 ,2 ,3 ,4 ,6 ]
Pomarol-Clotet, Edith [4 ,5 ]
Salvador, Raymond [4 ,5 ]
机构
[1] Hermanas Hosp, Hosp Mare Deu Merce, Neuropsychiat Unit, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, Barcelona, Spain
[3] European Huntingtons Dis Network EHDN, Ulm, Germany
[4] FIDMAG Germanes Hospitalaries Res Fdn, Barcelona, Spain
[5] Mental Hlth Res Networking Ctr CIBERSAM, Madrid, Spain
[6] Neuropsychiat Unit, Avda Jorda 10, Barcelona 08035, Spain
关键词
Huntington?s disease; Neuropsychiatric symptoms; Longitudinal studies; Apathy; Irritability; Perseveration; PROBLEM BEHAVIORS ASSESSMENT; FUNCTIONAL DECLINE; SUICIDAL IDEATION; PBA-S; RELIABILITY;
D O I
10.1016/j.parkreldis.2022.11.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The relationship between neuropsychiatric symptoms (NPS) and other clinical dimensions in Huntington's disease (HD) is controversial. This longitudinal study analyzed the association between NPS and motor, cognitive and functional aspects of the disease along with other variables related to its clinical onset and progression.Methods: 639 early-moderate HD patients were assessed longitudinally (mean: 4.95 visits/5 years). Generalized linear mixed models were used to explore associations between NPS and the aforementioned aspects. Other variables previously reported as significant in smaller or cross-sectional studies were included in the models.Results: Significant associations found included a negative linear relationship between presence of depressed mood and illness duration (7.2% odds reduction of being depressed per year), a 7.6% increase in the odds of having irritability with increased chorea scores, a negative association (4.3% reduction in odds) between age at onset and aggression (i.e. earlier onset was related to a higher probability of having aggressive behaviors) and a negative association between irritability and the interference component of the Stroop test (3% odds change). Total functional capacity (TFC) was the most frequently associated factor with NPS, with apathy and persev-erative behavior having the strongest relations with TFC (22% and 18% increases in odds per unit reduction in TFC respectively).Conclusions: With the exception of irritability, NPS are not related to motor or cognitive variables in early -moderate HD. Total functional capacity (TFC) is the most frequently associated factor with NPS, with apathy and perseverative behavior having the strongest relations with TFC.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Characterization of neuropsychiatric symptoms in a group of individuals with manifest or pre-motor Huntington's disease in Medellin, Colombia.
    Vasquez, D.
    Agudelo, M.
    Gomez, C.
    Aguillon, D.
    Quintero, J.
    Rassi, S.
    Zuluaga, M.
    Pineda, D.
    Buritica, O.
    Lopera, F.
    EUROPEAN PSYCHIATRY, 2022, 65 : S453 - S453
  • [12] Striatal hypometabolism in premanifest and manifest Huntington's disease patients
    Alfonso Lopez-Mora, Diego
    Camacho, Valle
    Perez-Perez, Jesus
    Martinez-Horta, Saul
    Fernandez, Alejandro
    Sampedro, Frederic
    Montes, Alberto
    Andrea Lozano-Martinez, Gloria
    Gomez-Anson, Beatriz
    Kulisevsky, Jaime
    Carrio, Ignasi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2183 - 2189
  • [13] Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease
    Aziz, N. A.
    Anguelova, G. V.
    Marinus, J.
    van Dijk, J. G.
    Roos, R. A. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (08) : 1068 - 1074
  • [14] Early-motor phenotype relates to neuropsychiatric and cognitive disorders in huntington's disease
    Julayanont, Parunyou
    Heilman, Kenneth M.
    McFarland, Nikolaus R.
    MOVEMENT DISORDERS, 2020, 35 (05) : 781 - 788
  • [15] Neurophysiological correlates of non-motor symptoms in late premanifest and early-stage manifest huntington's disease
    Davis, Marie-Claire
    Hill, Aron T.
    Fitzgerald, Paul B.
    Bailey, Neil W.
    Stout, Julie C.
    Hoy, Kate E.
    CLINICAL NEUROPHYSIOLOGY, 2023, 153 : 166 - 176
  • [16] Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease
    Bouwens, J. A.
    Hubers, A. A. M.
    van Duijn, E.
    Cobbaert, C. M.
    Roos, R. A. C.
    van der Mast, R. C.
    Giltay, E. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (08) : 1248 - 1256
  • [17] Lifetime neuropsychiatric symptoms in Huntington's disease: Implications for psychiatric nursing
    Gibson, Jessie S.
    Isaacs, David A.
    Claassen, Daniel O.
    Stovall, Jeffrey G.
    ARCHIVES OF PSYCHIATRIC NURSING, 2021, 35 (03) : 284 - 289
  • [18] Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease
    Spalletta, Gianfranco
    Musicco, Massimo
    Padovani, Alesandro
    Rozzini, Luca
    Perri, Roberta
    Fadda, Lucia
    Canonico, Vincenzo
    Trequattrini, Alberto
    Pettenati, Carla
    Caltagirone, Carlo
    Palmer, Katie
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (11) : 1026 - 1035
  • [19] Striatal hypometabolism in premanifest and manifest Huntington’s disease patients
    Diego Alfonso López-Mora
    Valle Camacho
    Jesús Pérez-Pérez
    Saül Martínez-Horta
    Alejandro Fernández
    Frederic Sampedro
    Alberto Montes
    Gloria Andrea Lozano-Martínez
    Beatriz Gómez-Anson
    Jaime Kulisevsky
    Ignasi Carrió
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2183 - 2189
  • [20] Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
    Wang, Rui
    Ross, Christopher A.
    Cai, Huan
    Cong, Wei-Na
    Daimon, Caitlin M.
    Carlson, Olga D.
    Egan, Josephine M.
    Siddiqui, Sana
    Maudsley, Stuart
    Martin, Bronwen
    FRONTIERS IN PHYSIOLOGY, 2014, 5